2010 ESRD Network of Texas, Inc. Network Coordinating Council Meeting.

Slides:



Advertisements
Similar presentations
Heart Failure and Transplant Medicine Council Immediate Past Chair: David A. Baran, MD Chair: Lee R. Goldberg, MD, MPH Vice-Chair Elect Brad Dyke MD.
Advertisements

Joint House Committee Hearing on Land & Resource Management and Urban Affairs October 15, 2014 Austin, Texas Population Growth of Texas Cities and Its.
Entering A New Era Together March 7, 2013 NEW Expectations, Activities and OPPORTUNITIES.
Chapter 4: Hospitalization 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
The State of CKD, ESRD and Mortality in the First Year on Dialysis: Are We Doing Enough? Allan J. Collins, MD, FACP Professor of Medicine University of.
Fistula First A Seminar for The Nephrology Community Corpus Christi, Texas July 31, 2004 Alamo City & Heart of Texas Chapters of The American Nephrology.
Chapter 12: USRDS Special Study Center on Transition of Care in CKD 2014 ANNUAL DATA REPORT VOLUME 1: CHRONIC KIDNEY DISEASE.
Texas & San Antonio: Characteristics and Trends of the Hispanic Population KVDA Telemundo November 10, 2011 San Antonio, TX.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
Chapter 5: Mortality 2014 A NNUAL D ATA R EPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE.
Summary of the 2012 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2014.
UK Renal Registry 17th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2013.
Texas Demographic Characteristics and Trends Midsize Agency Coordinating Council October 13, 2011 Austin, TX.
ROTARY CLUB CENTRAL Victoria Schiffman Club & District Support Rotary International.
“ Who We Are”. Objectives From this webinar we hope you will be able to: From this webinar we hope you will be able to: Define the role of ESRD networks.
RECENT EFFORTS BY CMS TO INCREASE IMMUNIZATION RATES AMONG MEDICARE BENEFICIARIES National Vaccine Advisory Committee Meeting James Randolph Farris, M.D.
CLIMATE CHANGE The True Vector of Yellow Fever Aedes africanus & others (sylvatic cycle) Aedes aegypti (urban cycle)
Texas and West Region: Demographic Characteristics and Trends AgriLife Regional Extension Leadership Program Conference March 30, 2012 Fredericksburg,
NATIONAL KIDNEY AND TRANSPLANT INSTITUTE
| 1| 1Peer Report: Dialysis Care & Outcomes in the U.S., 2014 | Mortality Peer Report: Dialysis Care & Outcomes in the U.S., 2014 Mortality.
UK Renal Registry 14th Annual Report Figure 3.1. Transplant prevalence rate per million population by age and gender on 31/12/2010.
Understanding Health Disparities in Texas Maureen Rubin, Ph.D., MSW Assistant Professor Department of Social Work University of Texas at San Antonio Nazrul.
Southwest Region Executive Directors Association November 13, 2014 San Antonio, Texas Demographic and Economic Characteristics, Trends, and Challenges.
CHRONIC KIDNEY DISEASE National Healthcare Quality and Disparities Report Chartbook on Effective Treatment.
2006 Executive Council Input President Submitted by Larry Jones July 30-31, 2006 Marriott Hotel Albuquerque, New Mexico, U.S.A.
1 Passport Advantage A Special Needs Plan for Dual Eligibles April 20, 2006.
Healthy People 2010 Focus Area 4
Texas Demographic Data Users Conference May 22, 2014 Austin, Texas.
USRDS 1998 II , ,515 74,116 51,762 Period Prev. Point Prev. Incidence Deaths LFU** Counts (1000s) Year *Preliminary **Lost-to-Followup Reported.
Chapter Elections IEEE Central Texas Section Chapter Officer Training Feb 11, 2014 Austin, TX.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 8: Pediatric ESRD.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 6: Mortality.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 7: Transplantation.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 10: Dialysis Providers.
USRDS 1999 Point Prevalence Counts by Modality, Data Source, and Year, Count (1000s) Year Center Hemo Functioning Transplant PD Home Hemo Facility.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 5: Hospitalization.
Summary of the 2013 ERA-EDTA Registry Annual Report Amsterdam, the Netherlands, 2015.
UK Renal Registry 17th Annual Report Figure 4.1. RRT treatment used by prevalent paediatric patients
Demographic Characteristics and Trends in Texas: Implications for Colleges and Universities Texas Association of State Senior College and University Business.
Are We Still Worlds Apart? Racial and ethnic disparities in kidney transplantation November 16, 2015 Vanessa Grubbs, MD, MPH Assistant Professor Division.
USRDS USRDS 2002 adr Period prevalent ESRD patient, deaths, & ESRD expenditures figure 12.1.
USRDS 2000 ADR USRDS Hepatitis B vaccine & antibody among patients & unit staff figure 9.1, dialysis patients, 1997, by network.
USRDS USRDS 2002 adr Incident counts by initial modality figure 7.1 patients age 19 years & younger.
USRDS 2000 ADR USRDS Cadaveric donations by gender & race figure 7.1, patients aged
Texas Population Projections
2016 Annual Data Report, Vol 2, ESRD, Ch 5
UK Renal Registry 13th Annual Report
2016 Annual Data Report, Vol 2, ESRD, Ch 6
Healthy People 2010 targets & levels achieved in 2000 figure hp.1
Figure 10.1 Dialysis unit counts, by unit affiliation, 2011–2014
First-year death rates by modality figure 8
Odd ratio of developing kidney failure figure 1
Patient populations by study group figure 10
Volume 2: End-Stage Renal Disease
Summary of the 2013 ERA-EDTA Registry Annual Report
December 31st point prevalent counts by modality figure 3.1
UK Renal Registry 18th Annual Report
Hospital admissions per patient, by modality figure 5
UK Renal Registry 9th Annual Report 2006
Basic Republican Party Structure
Volume 2: End-Stage Renal Disease
Impact of renal disease in cardiovascular surgery: emphasis on the African-American patient  William A Cooper, MD, William Brinkman, MD, Rebecca J Petersen,
2018 GAHE Organizational Structure
Reported ESRD Period and Point Prevalence,
American Journal of Kidney Diseases
IEEE CTS ExCom Meeting Agenda Morning
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Meeting Agenda 07:30 Coffee, Sign-in & Fare
Meeting Agenda 07:30 Coffee, Sign-in & Fare
Worldwide incidence of ESRD figure 12.1, per million population
Presentation transcript:

2010 ESRD Network of Texas, Inc. Network Coordinating Council Meeting

CHAIRMAN’S REPORT Melvin Laski, MD Network Elections Network Elections Network Growth Network Demographics Supporting Quality Care

NOMINATING COMMITTEE Melvin Laski, Lubbock Melvin Laski, Lubbock Richard Gibney, MD, Waco Richard Gibney, MD, Waco Robert Hootkins, MD, Austin Robert Hootkins, MD, Austin Cleve Collins, MD, San Antonio Cleve Collins, MD, San Antonio Tom Lowery, MD, Tyler Tom Lowery, MD, Tyler

10-11 EXECUTIVE COMMITTEE Melvin Laski, MD, Chairman Manny Alvarez, MD, Vice Chairman Larry McGowan, Treasurer Amy Hackney, Secretary Richard Gibney, MD Immediate Past Chairman Ruben Velez, MD, MRB Chair Laura Yates, RN, At Large Charles Orji, MD, At Large Leigh Anne Tanzenburger, At Large Slate of Officers

Network Coordinating Council Election

Insert any words/ topics you would like to address

2009 Network #14 Growth & Trends CMS Certified FacilitiesCMS Certified Facilities Facility Ownership Facility Ownership Growth in Patient Census Growth in Patient Census Patients Transplanted Patients Transplanted

NETWORK GROWTH 8 CMS Annual Facility Survey Data

9 Number of Patients 35,630 9,327 6,207

Texas & National Mortality 10

Cause of Death 11 % Diabetic = 57.0

ESRD by Primary Diagnosis 12 Incident Prevalent

Prevalent Primary Diagnosis (%) 13

In-Center and Home Patients 14 Home Patients In-Center Patients Home Patients NumberPercent

Patients by Modality 15

Patients by Modality 16

Race of Prevalent Patients In Texas 17 Includes Hispanic

18 Prevalent Patient Gender (%)

Age of Prevalent Patients 19

Avg. Age of Prevalent Patient 20

Transplants by Race

Total Transplants by Donor Type 22

Percent of Patients Transplanted 23

Recognitions